Crossmark

Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics

Crossref DOI link: https://doi.org/10.1007/s13311-020-00910-w

Published Print: 2020-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Wang, Mei

Jiang, Xiaochun

Yang, Yongbo

Chen, Hongjin

Zhang, Chengfei

Xu, Haojun

Qi, Bin

Yao, Chengyun

Xia, Hongping https://orcid.org/0000-0001-6454-2333
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (NA)

National High-level Talent Youth Program of China (NA)
License Information

Text and Data Mining valid from 2020-10-01

Text and Data Mining valid from 2020-10-01

Version of Record valid from 2023-08-21
More Information

This article is maintained by: Elsevier

Article Title: Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-020-00910-w

Content Type: article

Copyright: Copyright © 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.